The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

Investing.com -- The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, developed by pharmaceutical company Novo Nordisk (NYSE:NVO).

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

Ozempic: Which Is Better ... Other brand names for semaglutide you might have heard of include Wegovy (a higher-dose semaglutide injection FDA-approved for weight loss) and Rybelsus (a tablet ...

The findings exceed the typical weight loss results seen with the existing semaglutide-based drugs Ozempic and Wegovy ... the medication schedule (a weekly injection under the skin), those ...

However, it contains the same active ingredient — semaglutide — as Ozempic and Wegovy ... participants took a once-weekly semaglutide injection or a placebo for 68 weeks.

Ozempic and other semaglutide injections such as Wegovy have been in short supply for years due to their rapid popularity. The FDA now lists Ozempic as "available," but there is still high demand.

Investing.com -- The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, developed by pharmaceutical company Novo Nordisk (NYSE:NVO).

establishes Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg as the most broadly indicated glucagon-like peptide-1 receptor agonist (GLP-1 RA) in its class,” the release noted. In 2020 ...